Anaptysbio (ANAB) Enterprise Value Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Anaptysbio | 1.60 Bn | 1.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.74% |
| Dec 31, 2025 | 10.95% |
| Sep 30, 2025 | 17.48% |
| Jun 30, 2025 | 15.61% |
| Mar 31, 2025 | 12.40% |
| Dec 31, 2024 | 11.08% |
| Sep 30, 2024 | -4.76% |
| Jun 30, 2024 | -1.82% |
| Mar 31, 2024 | 2.30% |
| Dec 31, 2023 | 0.23% |
| Sep 30, 2023 | -6.88% |
| Jun 30, 2023 | -4.36% |
| Mar 31, 2023 | -5.95% |
| Dec 31, 2022 | -5.64% |
| Sep 30, 2022 | -1.71% |
| Jun 30, 2022 | -1.55% |
| Mar 31, 2022 | -6.75% |
| Dec 31, 2021 | -8.67% |
| Sep 30, 2021 | 8.84% |
| Jun 30, 2021 | -7.45% |
| Mar 31, 2021 | -15.30% |
| Dec 31, 2020 | -16.59% |
| Sep 30, 2020 | -42.99% |
| Jun 30, 2020 | -52.59% |
| Mar 31, 2020 | -51.86% |
| Dec 31, 2019 | -94.03% |